VBI-2901

N/A

Report date: 2022/11/15 16:39:49

Base Information

Drug NameVBI-2901
Drug Alias NameVBI-2901VBI-2901aVBI-2901e
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus InfectionsSevere Acute Respiratory Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVbi Vaccines Inc
China Registration ClassN/A

Develop Information

Active CompaniesVbi Vaccines Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus InfectionsSevere Acute Respiratory Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A